2014 Newsletter

In this edition: Sinusys earns FDA clearance for its Vent-Os Sinus Dilation System. Heart Metabolics is awarded Orphan Drug Designation for a medication to treat hypertrophic cardiomyopathy. Armetheon has completed a Special Protocol Assessment for its anticoagulant....